Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,319,000 | 2,894,000 | 2,038,000 | 5,360,000 | 3,815,000 |
| Marketable Securities | 2,815,000 | 14,555,000 | 4,079,000 | 7,841,000 | 4,140,000 |
| Receivables | 9,873,000 | 8,310,000 | 7,026,000 | 6,648,000 | 6,161,000 |
| Inventories | 6,093,000 | 5,830,000 | 5,792,000 | 5,455,000 | 4,498,000 |
| Other current assets | 2,585,000 | 2,102,000 | 1,946,000 | 2,126,000 | 2,790,000 |
| TOTAL | $26,685,000 | $33,691,000 | $20,881,000 | $27,430,000 | $21,404,000 |
| Non-Current Assets | |||||
| PPE Net | 15,840,000 | 14,075,000 | 13,100,000 | 12,633,000 | 10,945,000 |
| Investments And Advances | 10,225,000 | 20,426,000 | 17,712,000 | 6,945,000 | 6,111,000 |
| Intangibles | 64,923,000 | 22,370,000 | 20,819,000 | 21,249,000 | 21,230,000 |
| Other Non-Current Assets | 5,645,000 | 4,943,000 | 5,787,000 | 7,195,000 | 8,318,000 |
| TOTAL | $96,633,000 | $61,814,000 | $57,418,000 | $48,022,000 | $46,604,000 |
| Total Assets | $123,318,000 | $95,505,000 | $78,299,000 | $75,452,000 | $68,008,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,627,000 | 5,313,000 | 5,186,000 | 5,117,000 | 6,643,000 |
| Accounts payable and accrued liabilities | 4,788,000 | 4,012,000 | 3,395,000 | 3,018,000 | 2,487,000 |
| Other current liabilities | 9,533,000 | 8,329,000 | 6,547,000 | 6,787,000 | 5,736,000 |
| TOTAL | $24,658,000 | $19,470,000 | $16,504,000 | $16,641,000 | $16,234,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,360,000 | 8,675,000 | 2,178,000 | 677,000 | 656,000 |
| Other Non-Current Liabilities | 6,667,000 | 5,437,000 | 4,998,000 | 4,250,000 | 4,507,000 |
| TOTAL | $28,891,000 | $18,573,000 | $11,358,000 | $9,415,000 | $10,480,000 |
| Total Liabilities | $53,549,000 | $38,043,000 | $27,862,000 | $26,056,000 | $26,714,000 |
| Shareholders' Equity | |||||
| Common Shares | 957,000 | 957,000 | 959,000 | 990,000 | 990,000 |
| Retained earnings | 62,364,000 | 56,562,000 | 49,468,000 | 48,408,000 | 40,261,000 |
| Other shareholders' equity | 6,573,000 | 75,000 | 149,000 | 173,000 | 183,000 |
| TOTAL | $69,769,000 | $57,462,000 | $50,437,000 | $49,396,000 | $41,294,000 |
| Total Liabilities And Equity | $123,318,000 | $95,505,000 | $78,299,000 | $75,452,000 | $68,008,000 |